是时候跨越支持早期非小细胞肺癌肺段切除术的证据支柱了吗？
Is It Time to Cross the Pillars of Evidence in Favor of Segmentectomies in Early-Stage Non-Small Cell Lung Cancer?
作者信息
Bertolaccini Luca, Spaggiari Lorenzo
机构信息
Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
出版信息
Cancers (Basel). 2023 Mar 27;15(7):1993. doi: 10.3390/cancers15071993.
Abstract
In the debate on lobectomy versus segmentectomy for the treatment of early-stage non-small cell lung cancer (NSCLC), currently, we have reached two pillars of knowledge, like Jachim and Boaz, which have encompassed the actual boundary of the literature published up until now [...].
摘要
在关于肺叶切除术与肺段切除术治疗早期非小细胞肺癌（NSCLC）的争论中，目前，我们已经形成了两大知识支柱，就像雅斤和波阿斯一样，它们涵盖了迄今为止已发表文献的实际边界[...]。
相似文献
1
Is It Time to Cross the Pillars of Evidence in Favor of Segmentectomies in Early-Stage Non-Small Cell Lung Cancer?
Cancers (Basel). 2023 Mar 27;15(7):1993. doi: 10.3390/cancers15071993.
2
Oncologic outcomes of lobectomy segmentectomy in non-small cell lung cancer with clinical T1N0M0 stage: a literature review and meta-analysis.
J Thorac Dis. 2020 Jun;12(6):3178-3187. doi: 10.21037/jtd-19-3802.
3
Comparison of thoracoscopic segmentectomy and thoracoscopic lobectomy on the patients with non-small cell lung cancer: a propensity score matching study.
Eur J Cardiothorac Surg. 2015 Aug;48(2):273-8. doi: 10.1093/ejcts/ezu422. Epub 2014 Nov 18.
4
Segmentectomy versus lobectomy for stage I non-small cell lung cancer: a systematic review and meta-analysis.
J Thorac Dis. 2017 Jun;9(6):1615-1623. doi: 10.21037/jtd.2017.05.79.
5
Segmentectomy versus lobectomy in early non-small cell lung cancer of 2 cm or less in size: A population-based study.
Respirology. 2018 Jul;23(7):695-703. doi: 10.1111/resp.13277. Epub 2018 Feb 21.
6
Robotic segmentectomy for early-stage lung cancer.
Front Surg. 2023 Mar 23;10:1090080. doi: 10.3389/fsurg.2023.1090080. eCollection 2023.
7
Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM staging system).
Lung Cancer. 2019 Dec;138:19-26. doi: 10.1016/j.lungcan.2019.09.021. Epub 2019 Sep 27.
8
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.
Lancet. 2022 Apr 23;399(10335):1607-1617. doi: 10.1016/S0140-6736(21)02333-3.
9
Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the Polish National Lung Cancer Registry.
Eur J Cardiothorac Surg. 2017 Aug 1;52(2):363-369. doi: 10.1093/ejcts/ezx092.
10
Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cm.
Lung Cancer. 2022 Oct;172:108-116. doi: 10.1016/j.lungcan.2022.08.013. Epub 2022 Aug 24.
引用本文的文献
1
A comparative study of robot-assisted thoracoscopic surgery and conventional approaches for short-term outcomes of anatomical segmentectomy.
Gen Thorac Cardiovasc Surg. 2024 May;72(5):338-345. doi: 10.1007/s11748-023-01983-y. Epub 2023 Nov 7.
2
Real-world survival outcomes of wedge resection versus lobectomy for cT1a/b cN0 cM0 non-small cell lung cancer: a single center retrospective analysis.
Front Oncol. 2023 Aug 17;13:1226429. doi: 10.3389/fonc.2023.1226429. eCollection 2023.
3
Next-Generation Lung Cancer Surgery: A Brief Trip into the Future of the Research.
J Clin Med. 2023 May 15;12(10):3479. doi: 10.3390/jcm12103479.
本文引用的文献
1
Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.
N Engl J Med. 2023 Feb 9;388(6):489-498. doi: 10.1056/NEJMoa2212083.
2
The Society of Thoracic Surgeons General Thoracic Surgery Database: 2022 Update on Outcomes and Research.
Ann Thorac Surg. 2023 Jan;115(1):43-49. doi: 10.1016/j.athoracsur.2022.10.025. Epub 2022 Oct 29.
3
Invited commentary: indigo carmine and lipiodol mixture marking in lung segmentectomy.
Eur J Cardiothorac Surg. 2022 Sep 2;62(4). doi: 10.1093/ejcts/ezac469.
4
Commentary: The sublobar resections and the difference between a conjecture and a theorem.
J Thorac Cardiovasc Surg. 2023 Mar;165(3):862-863. doi: 10.1016/j.jtcvs.2022.06.002. Epub 2022 Jun 8.
5
The impact of segmentectomy versus lobectomy on pulmonary function in patients with non-small-cell lung cancer: a meta-analysis.
J Cardiothorac Surg. 2022 May 7;17(1):107. doi: 10.1186/s13019-022-01853-3.
6
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.
Lancet. 2022 Apr 23;399(10335):1607-1617. doi: 10.1016/S0140-6736(21)02333-3.
7
What Do We Talk About Now When We Talk About Segmentectomy for GGO?
Front Surg. 2022 Feb 15;9:831246. doi: 10.3389/fsurg.2022.831246. eCollection 2022.
8
Risk of bias: why measure it, and how?
Eye (Lond). 2022 Feb;36(2):346-348. doi: 10.1038/s41433-021-01759-9. Epub 2021 Sep 30.
9
Systematic Versus Lobe-Specific Mediastinal Lymphadenectomy for Hypermetabolic Lung Cancer.
Ann Surg Oncol. 2021 Nov;28(12):7162-7171. doi: 10.1245/s10434-021-10020-2. Epub 2021 Jul 3.
10
Intraoperative Lymph Node Management During Non-small Cell Lung Cancer Surgery.
Ann Surg Oncol. 2021 Nov;28(12):6925-6926. doi: 10.1245/s10434-021-10039-5. Epub 2021 Apr 16.
Zotero 插件